| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 08/31/2006 | WO2006090286A2 Method of obtaining a population of human haemopoietic stem cells |
| 08/31/2006 | WO2006089950A2 Expression cassettes for seed-preferential expression in plants |
| 08/31/2006 | WO2006089911A2 Expression cassettes for seed-preferential expression in plants |
| 08/31/2006 | WO2006089910A1 Transgenic animal as a model for fibrotic diseases |
| 08/31/2006 | WO2006089353A1 Immortalised feeder cells |
| 08/31/2006 | WO2006073563A3 Fluorescent affinity tag to enhance phosphoprotein detection |
| 08/31/2006 | WO2006071911A3 Expansion of definitive endoderm cells |
| 08/31/2006 | WO2006065975A3 Methods of treating ankylosing spondylitis using anti-tnf antibodies and peptides of human tumor necrosis factor |
| 08/31/2006 | WO2006044492A3 Methods for generating rat embryo-derived cell lines and genetic modification of rat genome |
| 08/31/2006 | WO2006040574A3 Lipocalin protein |
| 08/31/2006 | WO2006007529A3 Immunosuppressive exosomes |
| 08/31/2006 | WO2005076732A3 Peptide-pna chimera targeting inducible nitric oxide synthase |
| 08/31/2006 | WO2005027631A3 Proteins which confer biotic and abiotic stress resistance in plants |
| 08/31/2006 | US20060195954 Inbred corn line PHAJE |
| 08/31/2006 | US20060195953 Inbred corn line PH907 |
| 08/31/2006 | US20060195952 Inbred corn line wbb53 |
| 08/31/2006 | US20060195951 Cotton variety FM 989B2R |
| 08/31/2006 | US20060195950 hybrid seeds and transgenic plants having herbicide, insect and disease resistance; genetic engineering; foods |
| 08/31/2006 | US20060195947 Variant polypeptides having enhanced ketoreductase activity and/or thermostability for use in the stereospecific reduction of ketones; non-naturally occurring ketoreductas polypeptide capable of converting ethyl 4-chloroacetoacetate to ethyl (S)-4-chloro-3-hydroxybutyrate |
| 08/31/2006 | US20060195945 Method for preparing fusion polypeptide comprising epidermal growth factor and human serum albumin in plants |
| 08/31/2006 | US20060195944 Such as increased biomass, tolerance to cold, drought, and low nitrogen; making transgenic plants |
| 08/31/2006 | US20060195943 plant size, vegetative growth, organ number, plant architecture and/or biomass that are altered with respect to wild type plants; food product |
| 08/31/2006 | US20060195940 Transgenic plants having a modified carbohydrate content |
| 08/31/2006 | US20060195939 Delta-8 desaturase and its use in making polyunsaturated fatty acids |
| 08/31/2006 | US20060195938 Polynucleotides encoding insect acetyl coenzyme-A carboxylase and uses thereof |
| 08/31/2006 | US20060195937 Compositions and methods for genetic modification of plants |
| 08/31/2006 | US20060195936 Methods and compositions for tobacco plants with reduced nicotine |
| 08/31/2006 | US20060195935 Selection of host cells expressing protein at high levels |
| 08/31/2006 | US20060195933 Inbred sweet corn line R420B |
| 08/31/2006 | US20060195931 Soybean cultivar 4136015 |
| 08/31/2006 | US20060195930 Soybean cultivar 3133014 |
| 08/31/2006 | US20060195929 Soybean cultivar S040132 |
| 08/31/2006 | US20060195928 Soybean Cultivar 4328386 |
| 08/31/2006 | US20060195927 Soybean cultivar 1339013 |
| 08/31/2006 | US20060195926 Soybean cultivar 4441080 |
| 08/31/2006 | US20060195925 Seeds and plants produced by crossing the cultivar with itself or another soybean variety; hybrid soybean seeds by mutagenesis or transformation; soybean variety can be used in crosses with other soybean plants to produce first generation soybean hybrids with disease, insect, herbicide resistance |
| 08/31/2006 | US20060195924 Soybean cultivar S040131 |
| 08/31/2006 | US20060195923 Soybean cultivar 4929388 |
| 08/31/2006 | US20060195922 Soybean cultivar 4817034 |
| 08/31/2006 | US20060195919 Arabidopsis promoters |
| 08/31/2006 | US20060195918 reporter constructs for stem cell pluripotency and differentiation; bacterial artificial chromosome |
| 08/31/2006 | US20060195188 Biosynthetic composite for osteochondral defect repair |
| 08/31/2006 | US20060195179 Method for creating an internal transport system within tissue scaffolds using computer-aided tissue engineering |
| 08/31/2006 | US20060194951 Polynucleotides encoding interferon gamma polypeptides |
| 08/31/2006 | US20060194750 Methods and materials for modulating trpc4 |
| 08/31/2006 | US20060194735 Extending the shelf life of Therapeutic protein X; nucleic acids and vectors containing them; kits; treating, preventing, or ameliorating diseases, disorders or conditions |
| 08/31/2006 | US20060194734 Cardiac muscle function and manipulation |
| 08/31/2006 | US20060194733 Substantially non-immunogenic injectable collagen |
| 08/31/2006 | US20060194731 Using tumor antigens to elicit immune response targeted to cancer cells; immunotherapy |
| 08/31/2006 | US20060194721 Tissue regeneration |
| 08/31/2006 | US20060194323 Defined systems for epithelial cell culture and use thereof |
| 08/31/2006 | US20060194322 Culture media compositions free of Fetal Bovine Serum |
| 08/31/2006 | US20060194321 Directed differentiation of embryonic stem cells and uses thereof |
| 08/31/2006 | US20060194320 Artificial immune organ |
| 08/31/2006 | US20060194319 Promoter substitution for immunoglobulin therapy |
| 08/31/2006 | US20060194318 Cultured cd14+ antigen presenting cells |
| 08/31/2006 | US20060194317 Expression of apoAI and variants thereof using spliceosome mediated RNA trans-splicing |
| 08/31/2006 | US20060194316 Stromal differentiated neuron-like cells for use in treatment of neurodegenerative, ischemic, spinal cord and ataxic disorders; tissue engineering; regenerative medicine |
| 08/31/2006 | US20060194315 Compositions and methods for the control, differentiaton and/or manipulation of pluripotent cells through a gamma-secretase signaling pathway |
| 08/31/2006 | US20060194314 Novel Bt toxin receptors from lepidopteran insects and methods of use |
| 08/31/2006 | US20060194312 Method of cell culture observation, carbon substrate for cell culture observation, and method for manufacture thereof |
| 08/31/2006 | US20060194293 Rb1 gene induced protein (rb1cc1) and gene |
| 08/31/2006 | US20060194291 Comprising human immunoglobulin g1 fc region, which mediates antibody-dependent cell-mediated cytotoxicity in presence of effector cells more effectively; binds fc gamma receptor iii with better affinity |
| 08/31/2006 | US20060194290 Polypeptide variants with altered effector function |
| 08/31/2006 | US20060194289 Method of production of recombinant proteins in eukaryote cells |
| 08/31/2006 | US20060194288 Nucleic acid molecules encoding endonucleases and methods of use thereof |
| 08/31/2006 | US20060194286 Apo-2LI and Apo-3 polypeptides |
| 08/31/2006 | US20060194283 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/31/2006 | US20060194282 Contains at least one mutation that reduces or eliminates the ability of the fluorescent protein to oligomerize; determining the pH of a sample, presence of an enzyme, and activity of an enzyme by variation of fluorescence; kits |
| 08/31/2006 | US20060194276 Specificity grafting of a murine antibody onto a human framework |
| 08/31/2006 | US20060194274 Method for producing ketocarotinoids in genetically modified, non-human organisms |
| 08/31/2006 | US20060194254 Method for identifying optimal binding ligands to a receptor |
| 08/31/2006 | US20060194248 Method of measuring human CYP3A inducibility |
| 08/31/2006 | US20060194244 Uses of a chemokine receptor for inhibiting HIV-1 infection |
| 08/31/2006 | US20060194219 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/31/2006 | US20060194192 Stabilization of cells and biological specimens for analysis |
| 08/31/2006 | US20060194191 Processing method for the long-term stabilization of biological red blood cell volume |
| 08/31/2006 | US20060193905 Direct cellular energy delivery system |
| 08/31/2006 | US20060193866 H pylori antigens |
| 08/31/2006 | US20060193861 Tumor necrosis factor receptors 6 alpha & 6 beta |
| 08/31/2006 | US20060193857 Modulation of Fc gamma receptors for optimizing immunotherapy |
| 08/31/2006 | US20060193856 Aglycosyl anti-CD154 (CD40 ligand) antibodies and uses thereof |
| 08/31/2006 | US20060193852 immunotherapy, preferably against B-cell malignancies such as non-Hodgkin lymphoma; single-chain multifunctional polypeptides comprising at least two binding sites specific for the CD19 and CD3 antigen; domains are arranged in the order VLCD19-VHCD19-VHCD3-VLCD3; vector; cell |
| 08/31/2006 | US20060193851 Human anti-factor IX/IXa antibodies |
| 08/31/2006 | US20060193848 Mammalian tumor susceptibility genes and their uses |
| 08/31/2006 | US20060193841 Method for the treatment of parkinson's disease |
| 08/31/2006 | US20060193840 Perivascular mesenchymal precursor cell induced blood vessel formation |
| 08/31/2006 | US20060193839 Time varying electromagnetic force ("TVEMF") expanded blood stem cells from a mammal, used for repair of tissues |
| 08/31/2006 | US20060193838 Method and composition for treating diabetes |
| 08/31/2006 | US20060193837 Method and composition for repairing epithelial and other cells and tissue |
| 08/31/2006 | US20060193836 Method and composition for repairing heart tissue |
| 08/31/2006 | US20060193835 Treatment of congestive heart failure |
| 08/31/2006 | CA2599430A1 Method of obtaining a population of human haemopoietic stem cells |
| 08/31/2006 | CA2599172A1 Method for the treatment of retinopathy of prematurity and related retinopathic diseases |
| 08/31/2006 | CA2598859A1 Transgenic animal as a model for fibrotic diseases |
| 08/31/2006 | CA2598823A1 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases |
| 08/31/2006 | CA2598525A1 Nerve regeneration promoting agent |
| 08/31/2006 | CA2598307A1 Expression cassettes for seed-preferential expression in plants |
| 08/30/2006 | EP1696030A1 TIE ligand homologues |
| 08/30/2006 | EP1696029A1 TIE ligand homologues |